Editorial
GLP-1 Receptor Agonist Weight Loss Therapy and Arthroplasty: Are Women at Greater Risk for Complications?
The Journal of Arthroplasty · 2026-05 · 41 (5) · 1331-1332
DOI: 10.1016/j.arth.2026.03.063 ↗Kurz gefasst
Editorial in der Zeitschrift The Journal of Arthroplasty, 2026-05. Verfasst von V Grace Browne und 2 weiteren Autor:innen. Die Arbeit nennt 12 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Browne, V. G., Suleiman, L. I., & Cohen-Rosenblum, A. R. (2026). GLP-1 Receptor Agonist Weight Loss Therapy and Arthroplasty: Are Women at Greater Risk for Complications?. The Journal of Arthroplasty, 41(5), 1331-1332. https://doi.org/10.1016/j.arth.2026.03.063
Vancouver
Browne VG, Suleiman LI, Cohen-Rosenblum AR. GLP-1 Receptor Agonist Weight Loss Therapy and Arthroplasty: Are Women at Greater Risk for Complications?. The Journal of Arthroplasty. 2026;41(5):1331-1332. doi:10.1016/j.arth.2026.03.063
BibTeX
@article{Browne2026,
author = {Browne, V Grace and Suleiman, Linda I and Cohen-Rosenblum, Anna R},
title = {GLP-1 Receptor Agonist Weight Loss Therapy and Arthroplasty: Are Women at Greater Risk for Complications?},
journal = {The Journal of Arthroplasty},
year = {2026},
volume = {41},
number = {5},
pages = {1331--1332},
doi = {10.1016/j.arth.2026.03.063}
}
EUVIMED